Merrimack Pharmaceuticals Inc
MACK
Get informed when a big investor buys or sells
+ FollowMarket Cap$223.97M
Close$
$0.42
97.2% downside
Current Fair Value
97.2% downsideOvervalued by 97.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $223.97 Million |
|---|---|
| Enterprise Value | $-10,189,682.00 |
| Dividend Yield | $15.10 (-) |
| Earnings per Share | $-0.08 |
| Beta | 1.42 |
| Outstanding Shares | 14,452,000 |
Return
| Return on Equity | -11.07% |
|---|---|
| Return on Assets | -10.04% |
| Return on Invested Capital | -1.14% |
Valuation & Multiples
| P/E Ratio | -183.37 |
|---|---|
| PEG | -0.74 |
| Price to Sales | - |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 4.02 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data